PVSRIPO for Recurrent Glioblastoma (GBM)
Clinical trial NCT01491893 · COMPLETED
Trial details
- NCT number
- NCT01491893
- Sponsor
- Istari Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-25
- Primary completion
- 2017-06-27
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.